Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations

Summary Objectives Our objective was to identify evidence on the protection achieved by single-dose use of inactivated hepatitis A vaccines in order to evaluate the potential of a flexible booster administration in the form of a second dose. Methods A search was conducted for evidence on single-dose...

Full description

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2013-11, Vol.17 (11), p.e939-e944
Main Authors: Ott, J.J, Wiersma, S.T
Format: Article
Language:English
Subjects:
Booster
Dosage
Hepatitis A - prevention & control
Hepatitis A Vaccines - administration & dosage
Hepatitis A virus
Hepatitis A Virus, Human - immunology
Humans
Immunization Schedule
Immunization, Secondary
Inactivated vaccine
Infectious Disease
Pulmonary/Respiratory
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Objectives Our objective was to identify evidence on the protection achieved by single-dose use of inactivated hepatitis A vaccines in order to evaluate the potential of a flexible booster administration in the form of a second dose. Methods A search was conducted for evidence on single-dose administration of inactivated hepatitis A vaccine and its potential impacts on long-term seropositivity rates. The main pharmaceutical vaccine manufacturer federations and the corresponding authors of manuscripts were approached for additional epidemiologic data. Correspondence was also sent to the Argentinean Ministry of Health. Results We identified 15 data sources reporting on protection achieved by a single dose of inactivated hepatitis A vaccine. The consistent finding was that the immune and memory response to the booster dose, or post-booster geometric mean titer, was independent of the time since initial vaccination. The impact of the booster on seroprotection was the same across sexes and age-groups. The longest time interval between initial and booster dose was 10.67 years, indicating that booster doses can be highly immunogenic for up to 10.67 years after primary vaccination. Conclusions Protective anti-hepatitis A virus antibody levels after a single dose of inactivated hepatitis A vaccine can persist for almost 11 years and increase or reappear after booster vaccination. Further research on the vaccine doses needed to achieve long-term protection against hepatitis A infection is required.
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2013.04.012